GE Healthcare, a top international company in medical technology, pharmaceutical diagnostics, and digital solutions, has finished the first stage of testing for a unique MRI contrast agent made from manganese. According to an abstract presented at...
Exact Sciences Corp., a top supplier of cancer screening and diagnostic exams, disclosed that the Cologuard Plus test, the firm's advanced multitarget stool DNA test, was given the approval by the US Food and Drug Administration (FDA)...
AstraZeneca, a British company, has partnered exclusively with CSPC Pharmaceutical Group from China to further develop a new small molecule disruptor for Lipoprotein (a) (Lp(a)), which could provide extra benefits for dyslipidemia patients...
TiumBio Co., Ltd, a company specializing in biopharmaceuticals in the clinical development stage, revealed that the initial participant has been administered in the phase 2 clinical study of TU2218. TU2218 is a new oral inhibitor that targets both...
Akums Drugs & Pharmaceuticals Limited has joined forces with Apollo Hospitals to raise awareness during World Cancer Awareness Month. On October 5th, engaging awareness sessions were held at Akums' New Delhi Corporate Office and its subsidiary...
Messe Muenchen India successfully concluded its highly anticipated and largest edition of analytica Anacon India, India Lab Expo and Pharma Pro&Pack Expo on a record-breaking note at the HITEX Exhibition Centre in Hyderabad.
Approximately four billion individuals globally are in danger of arbovirus infections, with projections showing this number will rise to 5 billion by 2050. Dengue cases have increased in all six WHO regions, with the number of cases nearly...
Recipharm, a top global pharmaceutical CDMO, is enhancing its pharmaceutical development abilities by making strategic investments and incorporating advanced technologies. This investment enhances its offerings for both early and late-stage...
Liquidia Corporation and Pharmosa Biopharm have updated their exclusive licensing agreement for L606, an inhaled, sustained-release treprostinil formulation. The drug is currently in a clinical trial for treating pulmonary arterial hypertension...
Emcure Pharmaceuticals announced a royalty-free voluntary licensing agreement with Gilead Sciences Ireland UC, a subsidiary of the California-based Gilead Sciences, to manufacture and supply generic versions of lenacapavir, the antiretroviral...
, CDSCO.jpg)
